Personnel
Biotechnology company elects members to board of directors
Published in Gene Therapy Weekly, November 4th, 2004
Joseph Wender is an advisory director and senior director of the Financial Institutions Group at the global investment banking firm, Goldman, Sachs & Co., and Michael Khoury is a financial advisor and independent consultant. These additions bring Neurome's total board membership to six.
Commenting on the new appointments to the Board, Floyd E. Bloom, MD, chairman of the board and founding chief executive officer of Neurome, remarked, "Wender and Khoury, both seasoned biotech investors and experienced financial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-11-04)
More Articles from Gene Therapy Weekly
- Bioreactors
Polycation-mediated precipitation captures plasmid DNA from alkaline lysate - Breast Cancer
The adenoviral type 5 E1A gene sensitizes breast tumors to paclitaxel - Pancreatic Cancer
Suppressed synthesis of HMGA1 protein treats pancreatic carcinomas in mice - Tumor Suppression
Low-voltage electroporation augments antiangiogenic cancer gene therapy - Vector Development
Herpesvirus-based vector guides fusion protein to cancer cells - Acute Myeloid Leukemia
Loss of clone with FLT3 gene mutation at relapse does not improve AML prognosis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
